Earnings Axis
  • Politics
  • Business
  • Investing
  • Stock
  • Politics
  • Business
  • Investing
  • Stock
No Result
View All Result
Earnings Axis
No Result
View All Result
Home Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

July 28, 2025
in Investing
RAD receives IND approval from US FDA for Betabart (RV-01)

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

Previous Post

Maiden Drill Program Commences at Oasis Uranium Project

 Next Post

Freedom Caucus lawmaker Ralph Norman vows to ‘shake things up’ in South Carolina governor bid

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 earningsaxis.com | All Rights Reserved

    No Result
    View All Result
    • About us
    • Contact us
    • Home 1
    • Privacy Policy
    • Terms & Conditions
    • Thank you

    Copyright © 2025 earningsaxis.com | All Rights Reserved